ACSL5 is upregulated in several cancers such as colorectal cancer, ER-negative, basal and normal-like breast cancer subtypes, suggesting that the identification of specific ACSL5 inhibitors is of paramount importance. The gene discussed is ACSL5; the disease is breast carcinoma.